JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A8373 AZD2014

Summary: Novel mTOR inhibitor

≥23.15 mg/mL
A8381 BIBR-1048

Summary: Thrombin inhibitor

≥30 mg/mL
A8495 Oxybutynin

Summary: AChR antagonist

insoluble in H2O; ≥17.87 mg/mL
A8541 Triciribine
5 Citation

Summary: Akt inhibitor,highly selective

insoluble in H2O; insoluble in EtOH; ≥118.4 mg/mL
A8544 Wortmannin
12 Citation

Summary: PI3K inhibitor,selective and irreversible

≥21.42 mg/mL
A8620 AZD-3463
3 Citation

Target: ALK|Insulin-like growth factors (IGFs)

Summary: ALK/IGF1R inhibitor

insoluble in H2O; insoluble in EtOH; ≥11.22 mg/mL
A8656 Jervine

Summary: Hedgehog signaling Inhibitor

≥14.55 mg/mL
A8677 SLIGKV-NH2

Summary: PAR2 agonist
A8812 PD173955

Target: Bcr-Abl|Src

Summary: Dual Src/Abl kinase inhibitor, ATP-competitive,

≥22.15 mg/mL
B2206 PD123319

Target: Angiotensin AT2 Receptors

Summary: Angiotensin AT2 receptor antagonist

≥22.4 mg/mL